Microenvironment-Mediated Modeling of Tumor Response to Vascular-Targeting Drugs.

about

Microenvironment-Mediated Modeling of Tumor Response to Vascular-Targeting Drugs.

Item

http://www.wikidata.org/entity/Q39293041

description

2016 nî lūn-bûn

@nan

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

name

Microenvironment-Mediated Modeling of Tumor Response to Vascular-Targeting Drugs.

@en

Microenvironment-Mediated Modeling of Tumor Response to Vascular-Targeting Drugs.

@nl

type

Item

label

Microenvironment-Mediated Modeling of Tumor Response to Vascular-Targeting Drugs.

@en

Microenvironment-Mediated Modeling of Tumor Response to Vascular-Targeting Drugs.

@nl

prefLabel

Microenvironment-Mediated Modeling of Tumor Response to Vascular-Targeting Drugs.

@en

Microenvironment-Mediated Modeling of Tumor Response to Vascular-Targeting Drugs.

@nl

P1476

Microenvironment-Mediated Modeling of Tumor Response to Vascular-Targeting Drugs.

@en

P2093

Jana L Gevertz

http://www.w3.org/2001/XMLSchema#string

P2860

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

Modes of resistance to anti-angiogenic therapy

Angiogenesis in cancer and other diseases

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.

Temozolomide in patients with advanced cancer: phase I and pharmacokinetic study.

Bevacizumab and daily temozolomide for recurrent glioblastoma.

Prediction of glioblastoma multiform response to bevacizumab treatment using multi-parametric MRI.

VEGF-VEGF receptor complexes as markers of tumor vascular endothelium.

Computational modeling of tumor response to vascular-targeting therapies--part I: validation

A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment

P304

191-208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-3-319-42023-3_10

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

936

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27739049

http://www.w3.org/2001/XMLSchema#string